Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Dynavax Allergic Rhinitis TOLAMBA Trial

Trial Profile

Dynavax Allergic Rhinitis TOLAMBA Trial

Active, no longer recruiting
Phase of Trial: Phase III

Latest Information Update: 13 Feb 2007

At a glance

  • Drugs Ragweed allergy immunotherapy 1018-ISS conjugate (Primary)
  • Indications Seasonal allergic rhinitis
  • Focus Registrational; Therapeutic Use
  • Acronyms DARTT
  • Sponsors Dynavax Technologies
  • Most Recent Events

    • 13 Feb 2007 Interim 1-year results reported. Added to VAX.
    • 26 Jun 2006 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top